“VEGF/HGF-targeting DARPin MP0250”的概念、定义、翻译、参考文献-科学参考

A designed ankyrin repeat proteins (DARPin)-based agent targeting vascular endothelial growth factor (VEGF) and hepatocyte growth factor (HGF), with potential antiangiogenic and antineoplastic activities. Compared to antibodies, DARPins are small in size, have favorable pharmacokinetics and allow for both high affinity binding and efficacy. Upon administration, the VEGF/HGF-targeting DARPin MP0250 binds to and inhibits both HGF and VEGF. This prevents HGF- and VEGF-mediated signaling, and inhibits the growth of HGF/VEGF-overexpressing tumor cells. This agent also prevents osteolysis, due to the inhibitory effect on HGF signaling. HGF and VEGF are overexpressed in a variety of cancer cell types and are associated with increased cell proliferation, migration and adhesion.

单词	VEGF/HGF-targeting DARPin MP0250
释义	VEGF/HGF-targeting DARPin MP0250 A designed ankyrin repeat proteins (DARPin)-based agent targeting vascular endothelial growth factor (VEGF) and hepatocyte growth factor (HGF), with potential antiangiogenic and antineoplastic activities. Compared to antibodies, DARPins are small in size, have favorable pharmacokinetics and allow for both high affinity binding and efficacy. Upon administration, the VEGF/HGF-targeting DARPin MP0250 binds to and inhibits both HGF and VEGF. This prevents HGF- and VEGF-mediated signaling, and inhibits the growth of HGF/VEGF-overexpressing tumor cells. This agent also prevents osteolysis, due to the inhibitory effect on HGF signaling. HGF and VEGF are overexpressed in a variety of cancer cell types and are associated with increased cell proliferation, migration and adhesion.
随便看	synovial sarcoma Synovir synovitis Synribo Synribo synthesis synthesis phase synthetic synthetic brain tumor peptides-pulsed autologous dendritic cell vaccine synthetic breast cancer peptides-tetanus toxoid-Montanide ISA-51 vaccine synthetic breast cancer peptides-tetanus toxoid-poly ICLC vaccine synthetic colorectal tumor-associated peptides vaccine IMA910 synthetic glioblastoma mutated tumor-specific peptides vaccine therapy APVAC2 synthetic glioblastoma tumor-associated peptides vaccine therapy APVAC1 synthetic hTERT DNA vaccine INO-1400 synthetic human papillomavirus 16 E6 peptide synthetic human secretin synthetic human secretin synthetic hypericin synthetic long E6/E7 peptides vaccine HPV-01 synthetic melanoma-associated antigens vaccine synthetic peptide-based erythropoiesis stimulating agent synthetic peptides E-PRA and E-PSM vaccine synthetic protegrin analog synthetic retinoid